Evidence map›Paper›PMID 30770409›Full record

ArticleScience immunology2019

The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network.

Steven C Neier, Alejandro Ferrer, Katelynn M Wilton, Stephen E P Smith, April M H Kelcher, Kevin D Pavelko, Jenna M Canfield, Tessa R Davis, Robert J Stiles, Zhenjun Chen and 14 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Fetal Thymic Organ Culture and Negative Selection.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. In Vitro Analysis of Thymocyte Signaling.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Early expression of mature αβ TCR in CD4Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 3 countries.

Steven C NeierDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0003-2742-8608
Alejandro FerrerDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0002-4883-3023
Katelynn M WiltonDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0001-5060-8899
Stephen E P SmithDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0003-4180-573X
April M H KelcherDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0002-9665-2921
Kevin D PavelkoDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0001-7555-1315
Jenna M CanfieldMolecular Pathogenesis and Therapeutics PhD Graduate Program, University of Missouri, Columbia, MO, USA.ORCID 0000-0001-5980-7392
Tessa R DavisDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0003-0660-7850
Robert J StilesDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0001-8794-0019
Zhenjun ChenDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia.ORCID 0000-0003-1205-683X
James McCluskeyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia.ORCID 0000-0002-8597-815X
Scott R BurrowsQIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
Jamie RossjohnInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.ORCID 0000-0002-2020-7522
Deanne M HebrinkThoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Eva M CarmonaThoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Andrew H LimperThoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Dietmar J KappesBlood Cell Development and Cancer Keystone, Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Peter J WettsteinDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Aaron J JohnsonDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0002-7921-484X
Larry R PeaseDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Mark A DanielsDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA.ORCID 0000-0002-5175-9901
Claudia NeuhauserUniversity of Minnesota Informatics Institute, Minneapolis, MN, USA.ORCID 0000-0001-8932-675X
Diana GilDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA. schruma@health.missouri.edu gilpagesd@health.missouri.edu.ORCID 0000-0003-1744-3484
Adam G SchrumDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA. schruma@health.missouri.edu gilpagesd@health.missouri.edu.ORCID 0000-0001-9276-1859
Mayo Clinic · USUniversity of Missouri · USThe University of Melbourne · AUAustralian Regenerative Medicine Institute · AUFox Chase Cancer Center · USThe University of Queensland · AUUniversity of Minnesota · US

Funding

Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2014 to 2019
$7.9M
Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Postdoctoral Training Program in AIDS-related ResearchT32AI007386 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY, ENGELMAN, ALAN N. · 1990 to 2023
$5.3M
PHD TRAINING PROGRAM IN BASIC IMMUNOLOGYT32AI007425 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 1995 to 2020
$3.6M
Measuring multiprotein assemblies that drive biological signalsR01GM103841 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI SCHRUM, ADAM G. · 2013 to 2023
$3.3M
Mechanisms and consequences of CD3 rearrangement during TCR triggeringR01AI097187 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI GIL PAGES, DIANA · 2013 to 2018
$2.0M
Immune Contribution to Brain AtrophyR21NS094765 · NINDS · MAYO CLINIC ROCHESTER · PI JOHNSON, AARON J · 2016 to 2017
$498k
NIAID NIH HHS R01 AI097187NIAID NIH HHS T32 AI007386NIAID NIH HHS T32 AI007425NICHD NIH HHS U54 HD083091NIGMS NIH HHS R01 GM103841NIGMS NIH HHS T32 GM065841NINDS NIH HHS R21 NS094765
6 · The paper itself

Abstract

During αβ T cell development, T cell antigen receptor (TCR) engagement transduces biochemical signals through a protein-protein interaction (PPI) network that dictates dichotomous cell fate decisions. It remains unclear how signal specificity is communicated, instructing either positive selection to advance cell differentiation or death by negative selection. Early signal discrimination might occur by PPI signatures differing qualitatively (customized, unique PPI combinations for each signal), quantitatively (graded amounts of a single PPI series), or kinetically (speed of PPI pathway progression). Using a novel PPI network analysis, we found that early TCR-proximal signals distinguishing positive from negative selection appeared to be primarily quantitative in nature. Furthermore, the signal intensity of this PPI network was used to find an antigen dose that caused a classic negative selection ligand to induce positive selection of conventional αβ T cells, suggesting that the quantity of TCR triggering was sufficient to program selection outcome. Because previous work had suggested that positive selection might involve a qualitatively unique signal through CD3δ, we reexamined the block in positive selection observed in CD3δ

Indexed as

AnimalsCD3 ComplexCell DifferentiationMiceMice, Inbred C57BLMice, TransgenicPneumonia, PneumocystisProtein Interaction MapsProteomicsReceptors, Antigen, T-Cell, alpha-betaSignal TransductionTheilovirusThymocytesThymus GlandCD3 ComplexCD3delta antigenReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID30770409
PMCPMC7252671
OpenAlexW2912460249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.